chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received the expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 034F21A) for COVID-19 vaccination.     Concurrent medical conditions included Immune system disorder (Weakened immune system from premature birth) since 18-Feb-2001.    On 24-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED. On 24-Sep-2021, EXPIRED PRODUCT ADMINISTERED had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes on 08-Oct-2021 Follow up received and contains patient demographics, medical history, and product details, batch number updated.
Chills, fever 102.0, malaise, headache. 2 days.
Full body hives on back then spread to stomach and neck. Mom gave Benadryl every 6 hrs for two days until it was gone. Took to doctor about 15 hrs after reaction started and doctor said to keep giving Benadryl and watch for breathing difficulties. Mom and doctor decided to give vaccinations separately.  given Hep B on 8/22/17 and infant broke out in hives on 8/24/17 on back. Gave Benadryl one dose and rash went away.
Mom concerned regarding redden area left thigh thinks might have vaccine reaction. Previous MMR, Varicella shots no problems did use combination ProQuad. Keep checking it if worse make appointment.
no additional advers events; Caller is a nurse reporting that a pediatric dose of VAQTA was administered to a 21 year old adult patient on 24AUG2022. No additional information provided. No additional AE reported. No PQC reported.; a pediatric dose of VAQTA was administered to a 21 year old; This spontaneous report was received from a registered nurse concerning a 21-year-old patient of unknown gender.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 24-AUG-2022, the patient was vaccinated with a pediatric dose of hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, 0.5 milliliter, batch/lot #U102007, expiration date: 18-JAN-2023, administered as prophylaxis (strength, and route of administration were not provided) (product administered to patient of inappropriate age) (incorrect dose administered). No additional adverse events were reported.   Lot number U102007 is an invalid lot number for VAQTA as confirmed by lot verification team.
Tinnitus in both ears; Heavy fever; This is a spontaneous report from a contactable consumer (patient). A 26-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, administered in left arm on 11May2021 14:15 (at the age of 26-years-old) as 2nd dose, single for COVID-19 immunisation. The vaccine was administered at healthcare facility. The patient did not receive other vaccines in four weeks. The patient received the first dose of BNT162b2 on an unspecified date. The patient's medical history concomitant medications were not reported. The patient had no known allergies. On 12May2021 at 07:45 the patient experienced sudden tinnitus in both ears after heavy fever. The events were reported as serious due to disability. The patient did not receive treatment for events. Prior to vaccination the patient was not diagnosed with COVID-19 and he has not been tested for COVID-19. The events were not resolved.   Information on the lot/batch number has been requested.
History of seizure within 48 hours of vaccines lasted 20 minutes (mZ01, motor).
fever; chills; This is a spontaneous report from a contactable healthcare professional. This other HCP reported similar event for two patients. This is 2nd of 2 reports. A patient received 2nd dose of bnt162b2 (BNT162B2) on unknown date for COVID-19 immunization. Medical history and concomitant drugs were not provided. Historical vaccine included bnt162b2 for COVID-19 immunization. The patient had fever and chill with second dose on unknown date. X-ray was needed. The outcome of the events was unknown.   No follow-up attempts are possible. Information about Lot/Batch cannot be obtained. ; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021084250 same drug and event, different patient
arm pain; 1 degree increase in temperature; This is a spontaneous report from a contactable pharmacist (patient) via a Pfizer Sales Representative. A 40-year-old female patient (120 pounds) received first dose of BNT162B2, via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced arm pain and 1 degree increase in temperature on an unspecified date after receiving the first dose of the COVID 19 vaccine. The patient underwent lab tests and procedures which included body temperature: 1 degree increase on an unspecified date. The outcome of events was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
It is very red on the top and the bottom of the both the hands; Hand rash; This is a spontaneous report from a contactable consumer reporting for the mother.  A 79-year-old female received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, EL3246), via an unspecified route of administration, on 02Jan2021 at single dose for COVID-19 immunisation. Age at vaccination was 79-years-old. Medical history included diabetic. Concomitant medications included insulin glargine (LANTUS) and insulin lispro (HUMALOG) for diabetic. The patient got the vaccine on 02Jan2021 and she had no side effects or anything but the morning on 03Jan2021 when she woke up her hands have rash and it is very red on the top and the bottom of her hands, both the hands. She always has lab work done. Outcome was unknown. No treatment was received for the event.
I started feeling bad about a week after I had the shot. I noticed a heaviness on my chest. I was sweating and could not sleep. My friend took me to the hospital. I was hooked up to IV's and giving morphine. I was hospitalized for 4 days. I was put on 6 different pills for my heart including Eliquis. I was diagnosed with a fib and 2 weeks after I had cardio version to shock my heart back into normal sinus rhythm. That was successful but I am still take the 6 medications. I have not had any other issues. I have not been released from the heart doctors care.
Sometimes a lot of pain in chest. Sometimes less pain is always there. Sometimes pain in throat that it makes it difficult to pass saliva or food easily, a lot of phlegm secretion, cloudy vision in some occasions, headache, tiredness, hoarseness in throat, shortness of breath on several occasions, rapid cardiac rhythm, dryness in mouth and sometimes very thirsty.
Fever (101 F), chill, headache, body aches. Took ibuprofen and Tylenol 4 hours apart. Felt better by 3 pm.
On Monday  April 19th, 9 days after my 1st shot, I noticed a small blistered line on the back of my right calf. Over the last several days additional blister clusters have developed on both arms. Some have developed scabs. Other single bumps on both arms have begun to show up.
Headache, Sedation, Myalgia, Arthralgia, Fever, Diarrhea, Pain @ injection site Narrative:
I was scheduled to receive my second shot on February 19, 2001. However, due to the winter storm that hit I was not able too. The next week is when red bumps appeared all over my body from arms, legs, back, and chest. The clinic called for me to reschedule my second shot and I declined because of the rash. I waited another week hoping things would clear up but they never did. I proceeded to schedule an appointment with my primary care physician Dr. He treated it for scabies and gave me a prescription cream to use. After using the cream, nothing improved. I called doctor back and he referred me to a dermatologist. I have been waiting for almost a month now to see a dermatologist. In the meantime, I am still experiencing extreme itching and red bumps all over my body. Please help.
Client developed large red blotches/raised red welts on back, waist, arms, and neck the evening after flu vaccine was given.  Client also received a PPD Mantoux skin test (left forearm, Lot C2678AA), which was negative, 0 mm at 72 hours. She was taken to the emergency room at 8:30 pm that evening.  No fever, no change in usual blood pressure, no itching, no temperature elevation, no change in behavior of client.  In ER, client received an injection of diphendramine x 1,  and Zantac.  Prescribed oral prednisone qd x 7 days, Zantac bid x 7 days, and loratadine 10 mg qd x 7 days.  Client has finished with prednisone and loratadine today, and has last dose of Zantac this evening.  The client was noted to be "back to normal" the next morning.  Client has had flu shots in the past with no problems. Client has profound mental retardation due to PKU.  She has a public guardian.
Lying down to go to sleep--sudden lump in throat--dry cough approximately 15 minutes.  Sudden onset of chills, numbness and extreme cold in bilateral finger tips.  Coldness felt like it was slowly moving down entire body. took app. 2 hours to get warm again.  No fever--temp 97.9--took Tylenols 650mg--feel to sleep after warming up and felt fine the next morning 12/29/2020 & reported to work without any further reactions.
This spontaneous case was reported by a pharmacist and describes the occurrence of SYRINGE ISSUE (The syringe exploded and vaccine splashed out in to the pharmacist face), ACCIDENTAL EXPOSURE TO PRODUCT (The syringe exploded and vaccine splashed out in to the pharmacist face) and INFLUENZA LIKE ILLNESS (Flu like symptom) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history provided by reporter.  On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced SYRINGE ISSUE (The syringe exploded and vaccine splashed out in to the pharmacist face), ACCIDENTAL EXPOSURE TO PRODUCT (The syringe exploded and vaccine splashed out in to the pharmacist face) and INFLUENZA LIKE ILLNESS (Flu like symptom). On 03-Feb-2021, SYRINGE ISSUE (The syringe exploded and vaccine splashed out in to the pharmacist face) and ACCIDENTAL EXPOSURE TO PRODUCT (The syringe exploded and vaccine splashed out in to the pharmacist face) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptom) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patients concomitant medication include birth control pills. No treatment medication provided by reporter.
patient received a dose from a vial 24 hs after it was punctured; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 27-Jul-2021 and was forwarded to the company on 27-Jul-2021.    This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient received a dose from a vial 24 hs after it was punctured) in a 26-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient received a dose from a vial 24 hs after it was punctured). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient received a dose from a vial 24 hs after it was punctured) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant drug details were reported. No treatment details were reported.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 02-Aug-2021: Non significant follow up
Patient presented with chest pain approximately 15 hours after the 2nd Moderna COVID-19 vaccine. Workup was significant for an elevated troponin, sed rate, CRP, and D-dimer.  Cardiac MRI revealed myocarditis. Cardiac CT was negative for coronary disease. Treated with colchicine, metoprolol, and ibuprofen.
Pt reported redness and swelling at injection sight and pain. Also feeling weak and fatigue cannot get out of bed. Pt was told to put ice and take pain medication to help. Next day reported feeling a little better but still not fully recovered.
No adverse effect reported; pediatric dose of VAQTA being administered to an adult patient; This spontaneous report as received from a Certified Medical Assisstant via company representative refers to an adult patient of unknown age and gender. Patient's medical history, concurrent conditions and concomitant therapies were not provided.  On 09-JUL-2020, the patient was vaccinated with a pediatric dose of hepatitis a vaccine, inactivated (VAQTA) (dose, route of administration, lot # and expiration date were not provided) for prophylaxis. No adverse effects reported. Reporter would like to know the recommendations on whether that patient will need a re-peat dose, what precautionary steps they need to take, and how they should proceed.
Nauseous, light headed, pale and exhausted. All started around 12:00pm and haven?t gone away.
Mouth and throat tingling, feeling of lump in throat that would not resolve with swallowing or drinking (throat fullness)  started within 15min of injection. Had pre-medicated self with 25mg PO Benadryl 1hr prior to appt as well as Zyrtec 10mg the evening before. After reaction began, was given additional 25mg PO Benadryl by PA around 0915.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 63-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 06May2022 as dose 4 (booster), single (Lot number: DE002652) at the age of 63 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Symptoms came back and rapid test Positive again after 6days; Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical Information: No other medication received in 2 weeks. Anti-viral details product: covid 19 treatment, Brand: Pfizer, Treatment start date:09Aug2022, Treatment stop date:14Aug2022, Indication: treatment of covid-19. Patient had no known allergies.,  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on available information, a possible contributory role of Comirnaty vaccine cannot be excluded for the reported events of drug ineffective and covid-19.
Optic neuritis (bilateral) with decreased vision. Treated with Prednisone.
3 days after receiving my first dose, my body started attacking itself.  My joints everywhere hurt.  It got so bad that I couldn't bathe, dress or care for myself.  I was soon diagnosed with high blood pressure and RA.  Due to all the pain meds required to get me thru the day, I was taken to the ER twice and diagnosed with Colitis of the colon.  Recent colonoscopy has revealed that I have IBS due to medications.  I would never have taken this vaccination if I had known this was going to happen.  To this day I deal with brain fog, depression and colon pain.
Many floaters starting in right eye 3 days after first Pfizer.   Left eye started getting many floaters end of Feb 2022 with one week of headache plus one time migraine for 10 minutes.  Floaters caused difficulty to read computer screen at work, must take frequently breaks to avoid headache.  Dr. noticed the floaters but could not explain my symptom nor what he can do.  He asked me to come back seeing if the situation got worse.  The floaters and headache continue bothering me but I did not go back to see my doctor yet.  My current option is to taking break away from computer.
Experienced pain at injection site almost immediately. Ibuprofen taken with some relief. Fever of 101.5 in afternoon of 10/28/2014. Pain radiates down arm when raising arm with burning sensation in lower arm.
Symptoms: "fast heart beat" HR around 100-108. BP normal. No intervention. Resolved on its own.
pt recv vax 4OCT96 & 1OCT96 pt devel a small erythematous rash @ inj site;it was noted that pt was not exposed to nay new foods or soaps w/prev 72hr;dx urticaria;
Patient is feeling sweaty and dizzy. BP: 108/70. P:64, R:16. O2 SATs 96% on RA. Patient is diaphoretic and c/o feeling dizzy. After lying supine for 5 minutes. Pt no longer is diaphoretic and is feeling better. Water and snack provided. Continued to feel better and was ambulatory when leaving.
severe headache; they had left the vaccine in a freezer longer than it was; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the parent.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose: 2, Primary Immunization series complete but unknown manufacturer), for COVID-19 immunization; Covid-19 vaccine (Dose: 1, Primary Immunization series complete but unknown manufacturer), for COVID-19 immunization. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "severe headache"; PRODUCT STORAGE ERROR (non-serious), outcome "unknown", described as "they had left the vaccine in a freezer longer than it was".  Additional information: Attempted warm transfer from (name) with 159558. Agent relays he has a caller on the line and her daughter received the booster. reporter is the patient parent said that her daughter received a third dose on Monday, from a local pharmacy and they just called them and told that they had left the vaccine in a freezer longer than and reporter said that after her daughter received the vaccine she was been dealing with a severe headache, at entire time.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Pt had onset of vesicle type pruritic rash with low grade fever, general malaise and headache 5 days ago. The rash/vesicles scattered to upper torso, face, nose and legs. C/O itching and now vesicles scabbed over. Treatment was supportive therapy.
Body was shaking for 2 to 3 hours and have fever,pain all over the body,tiredness . I have taken one tablet acetaminophen 650 mg every 4 hours.
About ten hours after the injection, started having severe chills, N/V, severe headache, dizziness, fever, severe muscle soreness, active loss of smell and taste. General malaise and weakness.
10 days from vaccine administration pt developed small papule with surrounding erythema at site of vaccine administration.  Papule is dark, ~7mm in diameter, raised ~ 3mm rough, non-tender, non-fluctuant, ? mildly vescicular (but no clear areas noted for de-roofing, etc.), surrounded by silver-dollar sized area of normal temperature erythema and induration mildly tender to touch and non-fluctuant.  I took pictures with a digital camera.
Tiredness, headache, feeling un well. Took Acetaminophen  and rested at home for approx. 10 days.
Pt. received vaccine at 1805 and Pt. came to RN stating she felt heart racing at 1828. RN took patient to sit in observation area. Asked if any trouble breathing, stated no. RN noted patient with flushed face and red sclera. Patient placed on monitor with HR in 113, oxygen saturation 97% and blood pressure 186/108. Oral benadryl given at 1832 with water. Patient continue on monitor with HR in 107, at saturation 97% and blood pressure 186/103. 911 called at 1835 due to blood pressure issue and cont. flushed. EMT arrived 1842 and took over care. Pt. EKG done by them and then taken to ER at 1900.
tightness and discomfort in lungs/chest. from front of chest and feeling it in my back also; discomfort inlungs/chest. from front of chest andfeeling it in my back also; This is a spontaneous report received from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) via an unspecified route of administration in the left arm on 12Mar2021 at 16:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic obstructive pulmonary disease (COPD). The patient had a history of allergy to nonsteroidal anti-inflammatory drugs (NSAIDs). Concomitant medication included trazodone (MANUFACTURER UNKNOWN) 50mg once daily at night for an unknown indication received within two weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in Mar2021 about day 9 after the vaccination, the patient had experienced tightness and discomfort in lungs/chest, from front of chest and felt in her back also. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for events. The clinical outcome of the events tightness and discomfort in lungs/chest, from front of chest and felt in her back also was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.